Clinical Trial Update: Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update comparing Interleukin-11 and rhTPO for patients with recurrent colorectal cancer and thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Thrombocytopenia

Drugs mentioned

• Neumega (interleukin-11)
• rhTPO (recombinant human thrombopoietin)

Snippet

Sponsor: Fudan University | Conditions: Recurrent Colorectal Carcinoma, Thrombopenia | Phase 2 | Status: UNKNOWN